Connecting Lateral Flow to the 21st Century.
To find out more about Bond Health, I spoke to Phil Groom, Commercial Director, and Viktoriya Agova, Marketing Manager from Bond Health to hear how...
Billions of dollars have been pumped into medicinal cannabis. It’s popular with patients. The public’s perceptions are changing (for the better) and the competition isn’t nearly as tough as other markets in pharmaceuticals.
Decentralised, virtual, home, remote… whatever the name of this type of trial, it's widely agreed they will be crucial to advancing healthcare.
Connectivity is the future for labs, bringing countless benefits. Check out the forward-thinking companies leading this technology trend.
Analytical instruments are crucial to manufacturing and R&D, helping analyse materials to establish their composition. This data makes it easier to simplify processes, increase efficiency and productivity.
Heading into the proactive world of personalised care, data insights are providing us with more effective, targeted and preventative treatments for patients.
Returning from CPhI 2019, in Frankfurt, the words of Eric Langer, President of Bioplan Associates, have stuck with me. Forget the innovation, are biosimilars the real 'workhorse' carrying biopharma to bigger and better things?
Reported to correct 89% of pathogenic human gene variants, prime gene editing has the potential to target over 75,000 different mutations in treatment.
Pharma packaging is in transition. Companies are now pushing boundaries, furthering their offerings and innovating to be seen as true healthcare partners.
Our specialist in lab equipment and technology, Lucy Smith, is looking to get in touch with senior leaders in the life science space to learn more about connectivity.
A new generation of start-ups are revolutionising cancer diagnosis, detecting disease before patients even show symptoms with liquid biopsy tests. This innovation is rife in the US.
Globally, sepsis takes six million lives each year. It causes more deaths than breast cancer, lung cancer and stroke combined. Here are five diagnostics companies combating this ugly statistic.
There are countless benefits to companion diagnostics including better evidence of clinical utility & greater patient access, more efficient use of resources, better safety and economic advantages for drug companies.
Our Principal Consultant, Adam Butler, talks about the miracles of Stem Cell therapy, the issues surrounding it and the most high-profile case in the treatments' existence.